Radiology

Radiology
Audio Summaries

The literature in radiology doesn't slow down, and the papers you skip might be the ones that change your practice. OSLR turns the journals you'd read if you had the time into 3-minute audio summaries. Listen on your commute, between cases, whenever.

7 active journals591 audio summaries

Recent summaries

The latest articles summarized from radiology journals.

The Oncology Care Model and Medicare Payments, Utilization, and Quality

JAMA|Mar 25, 2026

The authors aimed to evaluate the impact of the Oncology Care Model (OCM) on Medicare spending, utilization, and quality of care for patients undergoing chemotherapy. They found that while the OCM was associated with modest reductions in Medicare payments during treatment episodes, it did not significantly improve care quality, and ultimately resulted in a net loss to Medicare due to enhanced services and performance-based payments.

A Placebo-Controlled Trial of the Oral PCSK9 Inhibitor Enlicitide

The New England journal of medicine|Mar 25, 2026

This study aimed to evaluate the efficacy of the oral PCSK9 inhibitor enlicitide in reducing LDL cholesterol levels in adults with a history of atherosclerotic cardiovascular disease or at risk for such events. The results demonstrated that enlicitide significantly lowered LDL cholesterol levels compared to placebo at both 24 and 52 weeks, with no notable difference in adverse events between the groups.

Proton beam therapy for oropharyngeal cancer (TORPEdO): a phase 3, randomised controlled trial

Lancet (London, England)|Mar 24, 2026

The authors conducted a phase 3 trial (TORPEdO) to compare the clinical benefits of intensity-modulated proton therapy (IMPT) versus intensity-modulated radiation therapy (IMRT) in patients with locally advanced oropharyngeal squamous cell carcinoma, specifically assessing treatment-related effects on physical function and quality of life. The results indicated that both treatment modalities yielded similar outcomes regarding late physical quality of life, gastrostomy-tube dependence, disease control, and overall survival, suggesting that IMRT remains the standard of care in settings where IMPT is not routinely utilized.

Outcomes from a Longitudinal Palliative Care Curriculum for Medical Students

Journal of palliative medicine|Mar 24, 2026

The authors aimed to evaluate the effectiveness of a longitudinal palliative care curriculum at the University of Pennsylvania's Perelman School of Medicine, focusing on its acceptability, impact on student knowledge and attitudes, and engagement in palliative care opportunities. Through a comprehensive assessment using both qualitative and quantitative methods, the study found that the curriculum successfully met its intended outcomes and provided valuable insights into its broader impacts. This evaluation serves as a model for other medical schools looking to assess similar palliative care educational initiatives.

Primary sclerosing cholangitis

Lancet (London, England)|Mar 23, 2026

This article investigates the clinical features, pathogenesis, and management challenges of primary sclerosing cholangitis (PSC), a rare chronic liver disease often associated with inflammatory bowel disease. The authors aim to clarify the disease's variable presentation, the role of genetic and environmental factors, including the intestinal microbiome, and the limited treatment options available. The seminar highlights the need for a deeper understanding of PSC to improve patient outcomes and management strategies.

Diagnosis and Management of Resistant Hypertension: A Review

JAMA|Mar 23, 2026

The authors aim to address the diagnosis and management of resistant hypertension, which affects approximately 10% of patients despite treatment. They highlight the importance of excluding factors such as white-coat hypertension and medication nonadherence, and recommend lifestyle modifications, optimized pharmacologic therapy, and interventions like spironolactone and renal denervation to effectively lower blood pressure in these patients.

The Inherited Basis of Coronary Artery Disease

The New England journal of medicine|Mar 23, 2026

The authors investigate the genetic underpinnings of coronary artery disease (CAD) and how these insights can enhance risk prediction, prevention, and treatment strategies. They highlight the significance of both monogenic and polygenic factors in CAD, emphasizing the potential of polygenic risk scores to improve individual risk assessment. Key questions remain about the practical application, cost-effectiveness, and integration of these genetic insights into clinical practice.

National Estimates of Pediatric Sepsis in US Hospitals Using Clinical Data

JAMA|Mar 22, 2026

The authors aimed to estimate the national incidence, mortality, and trends of pediatric sepsis in the U.S. using a Pediatric Sepsis Event (PSE) definition based on electronic health record (EHR) data, as traditional surveillance methods relying on administrative codes are often inaccurate. Their findings revealed a sepsis incidence of 1.3% among pediatric hospitalizations, with an in-hospital mortality rate of 10.1%, indicating that over 18,000 cases and 1,877 deaths occur annually, with no significant changes in incidence or mortality from 2016 to 2022. The PSE definition demonstrated strong validity, offering a more reliable method for identifying pediatric sepsis compared to existing administrative coding systems.

Efficacy and safety of oral semaglutide 14 mg (flexible dose) in early-stage symptomatic Alzheimer's disease (evoke and evoke+): two phase 3, randomised, placebo-controlled trials

Lancet (London, England)|Mar 22, 2026

The evoke and evoke+ trials aimed to evaluate the efficacy and safety of oral semaglutide (14 mg) in individuals with early-stage symptomatic Alzheimer's disease. The results indicated that semaglutide did not significantly slow clinical progression compared to placebo, and while safety profiles were consistent with other indications, the treatment did not demonstrate the expected benefits in this population.

Angiography-derived fractional flow reserve versus coronary angiography to guide coronary artery bypass grafting in patients undergoing surgical valve procedures with concomitant coronary artery disease in China (FAVOR IV-QVAS): a multicentre, triple-blind, randomised trial

Lancet (London, England)|Mar 21, 2026

The study aimed to determine whether a physiologically guided strategy using angiography-derived fractional flow reserve (FFR) could improve clinical outcomes compared to the traditional anatomically guided approach for coronary artery bypass grafting (CABG) in patients undergoing surgical valve procedures with concomitant coronary artery disease. Results showed that the FFR-guided CABG significantly reduced the incidence of adverse perioperative outcomes and long-term complications compared to the standard method, suggesting that physiological assessment may enhance surgical decision-making in this patient population.

Start listening to radiology research

14-day free trial. Pick your journals and go.